Truveta Expands AI-Driven Health Data Platform With New Intelligence Product and Knit Health Partnership

Truveta used its Truveta Symposium 2026 to debut Truveta Intelligence, an AI-driven analytics interface built on de-identified electronic health record data from more than 130 million patients. The platform is designed to deliver real-time insights from continuously refreshed real-world data, aiming to cut evidence-generation timelines from months to minutes.

Truveta Intelligence supports natural-language queries across patient journeys, treatment patterns, and outcomes, and is available to existing Truveta Data subscribers. Management is positioning the tool for use cases ranging from clinical decision support to trial design, commercialization strategy, and population health analytics.

The company also underscored its broader push into clinical AI, highlighting commentary from President and Chief Scientific Officer Johnathan M. Lancaster on integrating traditional literature with real-world data at the point of care. This integrated approach is intended to accelerate access to medical evidence and deepen Truveta’s value proposition for health systems and life sciences customers.

In parallel, Truveta announced a strategic collaboration with Knit Health to train a Large Clinical Behavior Model on its large-scale, regulatory-grade dataset. The partners aim to embed continuously learning models into clinical workflows, influencing routing, discharge predictions, care team allocation, and referrals while maintaining privacy through de-identified data.

Truveta also showcased its research capabilities, including a hantavirus study using longitudinal data from 2018 through April 2026 that identified 151 U.S. cases, and oncology-focused work that will be presented at ISPOR 2026. These projects, along with AI research on cancer risk prediction and screening, illustrate expanding use of the platform across high-value therapeutic areas.

Across these initiatives, Truveta is emphasizing regulatory- and privacy-conscious applications, audit-ready evidence generation, and real-time analytics as key differentiators. While financial metrics and specific commercial wins were not disclosed, the week’s developments highlight a strategy centered on AI-enabled decision support, deeper monetization of its data asset, and a growing role as core infrastructure for healthcare analytics and clinical AI.